Billie Kelley
Family · Irvine, KYNPI 1417061995
Payments from drug & device makers
Across 100 payments — averaging $17.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$297
- GSK$239
- Pfizer$194
- AstraZeneca$175
- Abbott$142
- Astellas Pharma US Inc$119
- plus $558 from 16 others
What the payments were for
- Food & beverage$1,64896%
- Education$754%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 18 | $297 |
| GSK | 16 | $239 |
| Pfizer | 11 | $194 |
| AstraZeneca(2 entities) | 6 | $175 |
| Abbott | 8 | $142 |
| Astellas Pharma US Inc | 4 | $119 |
| Novo Nordisk | 7 | $114 |
| Boehringer Ingelheim | 5 | $69 |
| Lilly USA, LLC | 4 | $61 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $51 |
| Johnson & Johnson | 3 | $48 |
| Sumitomo Pharma America, Inc. | 2 | $35 |
| Dexcom, Inc. | 2 | $28 |
| Amgen | 2 | $25 |
| Merck | 2 | $25 |
| Pulmonx Corporation | 1 | $17 |
| Madrigal Pharmaceuticals | 1 | $16 |
| Novartis | 1 | $15 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $14 |
| Nestle Healthcare Nutrition Inc. | 1 | $14 |
| Xeris Pharmaceuticals, Inc. | 1 | $12 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
How this compares
$1,723 in reported general payments places this provider in the 75th percentile of 4,374 family providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 146 | $140,418 |
| OzempicSemaglutide | 124 | $130,041 |
| FarxigaDapagliflozin Propanediol | 121 | $129,807 |
| JardianceEmpagliflozin | 137 | $125,549 |
| TrulicityDulaglutide | 73 | $116,815 |
| MyrbetriqMirabegron | 106 | $74,525 |
| XareltoRivaroxaban | 84 | $66,405 |
| VraylarCariprazine Hcl | 31 | $46,281 |
| LinzessLinaclotide | 50 | $43,555 |
| RybelsusSemaglutide | 24 | $42,073 |
| JanuviaSitagliptin Phosphate | 44 | $40,929 |
| Tresiba Flextouch U-200Insulin Degludec | 12 | $34,870 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 38 | $34,386 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 34 | $30,526 |
| TradjentaLinagliptin | 22 | $30,401 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort, Brilinta | $175 | $186,398223 claims |
| Boehringer IngelheimJardiance, Tradjenta, Combivent Respimat | $69 | $172,345185 claims |
| Novo NordiskOzempic, Rybelsus | $114 | $172,114148 claims |
| PfizerEliquis | $194 | $140,418146 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $61 | $134,89688 claims |
| AbbVieVraylar, Linzess, Creon | $297 | $95,95294 claims |
| Astellas Pharma US IncMyrbetriq | $119 | $74,525106 claims |
| Johnson & JohnsonXarelto | $48 | $66,40584 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta | $239 | $44,84867 claims |
| MerckJanuvia | $25 | $40,92944 claims |
| NovartisEntresto | $15 | $12,00714 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,374 family providers in Kentucky.
Other family in Irvine
- Bonnie HillLouisa$372K
- Ashley SnellenElizabethtown$190K
- Smita RanjanLouisville$92K
- Elizabeth SaltLexington$89K
- Tracey GaslinLouisville$79K
- Kassandra GreenLouisville$69K
- Danielle RevertLouisville$65K
- Lora BrownMonticellow$61K
- Shelley WaldmanLouisville$59K
- Vicki ChapmanMount Vernon$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.